
Genetically engineered biological agents in therapy for systemic lupus erythematosus
Author(s) -
Е. А. Асеева,
С. К. Соловьев,
Евгений Львович Насонов
Publication year - 2013
Publication title -
sovremennaâ revmatologiâ
Language(s) - English
Resource type - Journals
eISSN - 2310-158X
pISSN - 1996-7012
DOI - 10.14412/1996-7012-2013-11
Subject(s) - belimumab , medicine , lupus nephritis , biologic agents , intensive care medicine , rheumatology , systemic lupus erythematosus , disease , immunology , pathogenesis , lupus erythematosus , rheumatoid arthritis , antibody , b cell activating factor , b cell